Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FEV1”

140 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 140 results

Not applicableActive Not RecruitingNCT04354038
What this trial is testing

Host and Bacterial Mechanisms During Cystic Fibrosis Pulmonary Exacerbations

Who this might be right for
Cystic Fibrosis
National Jewish Health 100
Testing effectiveness (Phase 2)Study completedNCT01555099
What this trial is testing

Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 353
Testing effectiveness (Phase 2)Study completedNCT01437735
What this trial is testing

Dose Finding Study for QAW039 in Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 1,043
Not applicableStudy completedNCT00971490
What this trial is testing

Effects of a 4-week Acu-Transcutaneous Electrical Nerve Stimulation (Acu-TENS) Program on Subjects With Stable Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
The Hong Kong Polytechnic University 30
Not applicableStudy completedNCT03814018
What this trial is testing

Bronchoreversibility Test in Asthmatic Children and Correlation With Diagnostic Criteria Proposed by the GINA Guidelines

Who this might be right for
Pediatric Asthma
University Hospital, Montpellier 600
Testing effectiveness (Phase 2)Study completedNCT03064113
What this trial is testing

Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease, COPD
Mylan Inc. 32
Large-scale testing (Phase 3)Active Not RecruitingNCT05748600
What this trial is testing

Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

Who this might be right for
Eosinophilic AsthmaAsthma; EosinophilicAsthma Attack
Areteia Therapeutics 600
Testing effectiveness (Phase 2)Study completedNCT01287065
What this trial is testing

A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function

Who this might be right for
Asthma
GlaxoSmithKline 26
Not applicableStudy completedNCT01797367
What this trial is testing

Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)

Who this might be right for
Chronic Obstructive Pulmonary DiseaseHIV
University of Minnesota 1,026
Post-approval studies (Phase 4)Study completedNCT00483769
What this trial is testing

One Year Glargine Treatment in CFRD Children and Adolescents

Who this might be right for
Cystic FibrosisGlucose Metabolism Disorders
Federico II University 20
Large-scale testing (Phase 3)WithdrawnNCT01393145
What this trial is testing

Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD

Who this might be right for
Chronic Obstructive Pulmonary DiseaseCOPD
Ache Laboratorios Farmaceuticos S.A.
Large-scale testing (Phase 3)Study completedNCT01899742
What this trial is testing

The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 497
Post-approval studies (Phase 4)Ended earlyNCT00346749
What this trial is testing

ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 180
Large-scale testing (Phase 3)Study completedNCT01009463
What this trial is testing

Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 1,626
Testing effectiveness (Phase 2)Study completedNCT01054170
What this trial is testing

Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 52
Testing effectiveness (Phase 2)Ended earlyNCT00530166
What this trial is testing

Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.

Who this might be right for
Asthma
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 26
Not applicableStudy completedNCT02760290
What this trial is testing

Comparison of Extraperitoneal and Intraperitoneal Cesarean Technique

Who this might be right for
Postpartum FeverIleusHemorrhage+1 more
Zeynep Kamil Maternity and Pediatric Research and Training Hospital 50
Not applicableEnded earlyNCT00502554
What this trial is testing

Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation

Who this might be right for
Bronchiolitis Obliterans
Hannover Medical School 12
Testing effectiveness (Phase 2)WithdrawnNCT02960503
What this trial is testing

Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Vanderbilt University
Not applicableStudy completedNCT01013922
What this trial is testing

A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Setting

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 309
Load More Results